Shilpa Medicare Limited SHILPAMED

Latest filings

• Routine29 26 Sept, 14:23 · BSE
  The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 26, 2026 for Ramakant Innani & Others
• Routine15 25 Sept, 11:47 · NSE
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
• Credit rating73 23 Sept, 15:08 · NSE
  Assignment of ESG Rating by CRISIL ESG Ratings.
• Routine15 22 Sept, 15:45 · BSE
  Investors/Analysts meet
• Routine15 22 Sept, 15:11 · NSE
  Schedule of meet
• Approval73 18 Sept, 18:59 · NSE
  USFDA Inspection of Shilpa Medicare Limited, Unit VII, Analytical Services Division, Hyderabad.
• Routine15 12 Sept, 16:19 · BSE
  Submission of Scrutinizers Report on 39th AGM Resolutions along with Voting Results
• Routine15 12 Sept, 16:04 · NSE
  Voting results of Annual General Meeting held on September 11, 2026
• Approval70 11 Sept, 13:26 · NSE
  A press release dated September 11, 2026, titled "Shilpa Medicare's Novel Complex Injectable OERIS (Ondansetron Extended-Release Injection, 100 mg/mL) receives final approval from Subject Expert Committee (SEC) for grant of marketing authorization.".
• Routine15 11 Sept, 13:04 · NSE
  Proceedings of Annual General Meeting held on September 11, 2026

Shown 15 minutes after publication. Real time with Pro.

Upcoming corporate actions

No announced actions in the next 60 days.